Tom Würdinger

8.5k total citations · 2 hit papers
33 papers, 5.8k citations indexed

About

Tom Würdinger is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Tom Würdinger has authored 33 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Genetics. Recurrent topics in Tom Würdinger's work include Glioma Diagnosis and Treatment (9 papers), Extracellular vesicles in disease (8 papers) and MicroRNA in disease regulation (5 papers). Tom Würdinger is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Extracellular vesicles in disease (8 papers) and MicroRNA in disease regulation (5 papers). Tom Würdinger collaborates with scholars based in Netherlands, United States and Italy. Tom Würdinger's co-authors include Bob S. Carter, Dimphna H. Meijer, Xandra O. Breakefield, William T. Curry, Johan Skog, Anna M. Krichevsky, Sjoerd van Rijn, Mark C. de Gooijer, Olaf van Tellingen and Pieter Wesseling and has published in prestigious journals such as The EMBO Journal, Blood and Nature Cell Biology.

In The Last Decade

Tom Würdinger

33 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

2008 4.0k citations Johan Skog, Tom Würdinger et al. Nature Cell Biology profile →
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

2015 764 citations Olaf van Tellingen, Bahar Yetkin-Arik et al. Drug Resistance Updates profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Würdinger Netherlands	17	4.7k	3.0k	677	615	577	33	5.8k
An Hendrix Belgium	39	4.9k 1.0×	2.7k 0.9×	712 1.1×	800 1.3×	714 1.2×	96	6.1k
Michael W. Graner United States	38	4.0k 0.8×	2.0k 0.7×	488 0.7×	708 1.2×	1.4k 2.4×	94	5.6k
Mercedes Tkach France	20	7.3k 1.5×	3.9k 1.3×	763 1.1×	506 0.8×	1.6k 2.8×	25	8.3k
Leonora Balaj United States	37	8.1k 1.7×	5.0k 1.7×	1.6k 2.4×	827 1.3×	881 1.5×	73	9.6k
Alicia Llorente Norway	31	6.5k 1.4×	3.6k 1.2×	694 1.0×	251 0.4×	966 1.7×	67	7.5k
Charles Pin‐Kuang Lai United States	24	4.1k 0.9×	2.0k 0.7×	753 1.1×	225 0.4×	588 1.0×	41	4.8k
James N. Higginbotham United States	26	4.8k 1.0×	2.6k 0.9×	471 0.7×	719 1.2×	788 1.4×	48	5.8k
Luana Lugini Italy	31	5.3k 1.1×	3.0k 1.0×	722 1.1×	911 1.5×	1.6k 2.8×	39	6.7k
Paule Opolon France	44	3.5k 0.7×	1.3k 0.4×	696 1.0×	1.5k 2.4×	1.1k 1.9×	159	6.6k
Jeffrey L. Franklin United States	33	5.9k 1.2×	3.2k 1.1×	547 0.8×	799 1.3×	912 1.6×	66	7.0k

Countries citing papers authored by Tom Würdinger

Since Specialization

Citations

This map shows the geographic impact of Tom Würdinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Würdinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Würdinger more than expected).

Fields of papers citing papers by Tom Würdinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Würdinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Würdinger. The network helps show where Tom Würdinger may publish in the future.

Co-authorship network of co-authors of Tom Würdinger

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Würdinger. A scholar is included among the top collaborators of Tom Würdinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Würdinger. Tom Würdinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lagerweij, Tonny, S. Heukelom, Phil W. Koken, et al.. (2022). Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo. Journal of Cancer Research and Clinical Oncology. 149(1). 297–305. 6 indexed citations

Veld, Sjors G. J. G. In ‘t, Anna E. Huis in ‘t Veld, Nik Sol, et al.. (2022). Distinct Platelet Ribonucleic Acid Signatures in Patients with Pulmonary Hypertension. Annals of the American Thoracic Society. 19(10). 1650–1660. 2 indexed citations

Heinhuis, Kimberley M., Sjors G. J. G. In ‘t Veld, Daan van den Broek, et al.. (2020). RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics. Cancers. 12(6). 1372–1372. 41 indexed citations

Visser, Allerdien, Remco Keijser, Ankie Poutsma, et al.. (2020). The bivariate NRIP1/ZEB2 RNA marker permits non-invasive presymptomatic screening of pre-eclampsia. Scientific Reports. 10(1). 21857–21857. 5 indexed citations

Saleem, Hamza, Aslι Küçükosmanoğlu, Dieter Henrik Heiland, et al.. (2019). The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation. Drug Resistance Updates. 43. 29–37. 36 indexed citations

Sciarrillo, Rocco, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.. (2018). Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma. EBioMedicine. 39. 215–225. 47 indexed citations

Svensson, Fredrik, Ravi S. Narayan, Aslι Küçükosmanoğlu, et al.. (2018). WINDOW consortium: A path towards increased therapy efficacy against glioblastoma. Drug Resistance Updates. 40. 17–24. 16 indexed citations

Large, Tessa Y. S. Le, Laura L. Meijer, Nik Sol, et al.. (2018). Abstract 2596: Spliced messenger RNA of tumor-educated platelets yields a new diagnostic prospective for pancreatic cancer. Cancer Research. 78(13_Supplement). 2596–2596. 2 indexed citations

Dusoswa, Sophie A., Sophie K. Horrevorts, Sjoerd Schetters, et al.. (2018). EXTH-21. REPURPOSING GLIOBLASTOMA EXOSOMES AS PERSONALIZED MULTI-ANTIGENIC ANTI-TUMOR VACCINE. Neuro-Oncology. 20(suppl_6). vi89–vi89. 1 indexed citations

10.

Narayan, Ravi S., Tonny Lagerweij, Jaap van den Berg, et al.. (2017). Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma. Molecular Cancer Therapeutics. 17(2). 347–354. 19 indexed citations

11.

Lin, Fan, Mark C. de Gooijer, Diana Hanekamp, et al.. (2016). PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models. Clinical Cancer Research. 23(5). 1286–1298. 64 indexed citations

12.

Lagerweij, Tonny, Lotte Hiddingh, Matheus H. W. Crommentuijn, et al.. (2016). A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer. Oncotarget. 7(24). 35776–35788. 16 indexed citations

13.

Tellingen, Olaf van, Bahar Yetkin-Arik, Mark C. de Gooijer, et al.. (2015). Overcoming the blood–brain tumor barrier for effective glioblastoma treatment. Drug Resistance Updates. 19. 1–12. 764 indexed citations breakdown →

14.

Kuiper, Justine L., Daniëlle A.M. Heideman, Tom Würdinger, et al.. (2014). Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment. Clinical Lung Cancer. 16(1). 60–66. 9 indexed citations

15.

Thuijl, Hinke F. van, Bauke Ylstra, Tom Würdinger, et al.. (2012). Genetics and pharmacogenomics of diffuse gliomas. Pharmacology & Therapeutics. 137(1). 78–88. 4 indexed citations

16.

Verweij, Frederik J., Monique A.J. van Eijndhoven, Erik Hopmans, et al.. (2011). LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF‐κB activation. The EMBO Journal. 30(11). 2115–2129. 190 indexed citations

17.

Skog, Johan, Tom Würdinger, Sjoerd van Rijn, et al.. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology. 10(12). 1470–1476. 4003 indexed citations breakdown →

18.

Haan, Cornelis A. M. de, et al.. (2006). Cooperative Involvement of the S1 and S2 Subunits of the Murine Coronavirus Spike Protein in Receptor Binding and Extended Host Range. Journal of Virology. 80(22). 10909–10918. 47 indexed citations

19.

Würdinger, Tom, Monique H. Verheije, Matthijs Raaben, et al.. (2005). Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody. Gene Therapy. 12(18). 1394–1404. 30 indexed citations

20.

Beusechem, Victor W. van, Petra B. van den Doel, Martine L.M. Lamfers, et al.. (2003). Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Therapy. 10(23). 1982–1991. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact